BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6408299)

  • 1. Intra-individual comparison of the action of equal doses of isosorbide-5-endomononitrate, slow-release isosorbide dinitrate and placebo in patients with coronary heart disease.
    Müller G; Häcker W; Schneider B
    Klin Wochenschr; 1983 Apr; 61(8):409-16. PubMed ID: 6408299
    [No Abstract]   [Full Text] [Related]  

  • 2. [Randomized double-blind comparative study: glycerol trinitrate and isosorbide mononitrate].
    Kayali A
    Med Welt; 1983 Dec; 34(50):1441-4. PubMed ID: 6420639
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative clinical trial of isosorbide 5-mononitrate and sustained-release isosorbide dinitrate in ischaemic heart disease.
    Neuhaus R; Johnen R; Vydra L; Solbach C
    Pharmatherapeutica; 1986; 4(8):486-95. PubMed ID: 3086899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combined treatment of coronary heart disease with diltiazem and isosorbide dinitrate].
    Beythien RD
    Dtsch Med Wochenschr; 1983 Feb; 108(5):176-80. PubMed ID: 6402353
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of placebo, nitroglycerin, and isosorbide dinitrate for effectiveness of relief of angina and duration of action.
    Kattus AA; Alvaro AB; Zohman LR; Coulson AH
    Chest; 1979 Jan; 75(1):17-23. PubMed ID: 105834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [4 different nitrate preparations with regard to the possible development of tolerance in long-term treatment].
    Mertens HM; Ohlmeier H; Mannebach H; Kabelitz K; Gleichmann U
    Herz; 1985 Jun; 10(3):172-81. PubMed ID: 3926614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of sustained action isosorbide dinitrate on exercise performance in patients with ischemic heart disease.
    Brunner D; Meshulam N; Zerieker F
    Acta Cardiol; 1974; 29(4):281-93. PubMed ID: 4607749
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of swallowed isosorbide dinitrate on blood pressure, heart rate and exercise capacity in patients with coronary artery disease.
    Glancy DL; Richter MA; Ellis EV; Johnson W
    Am J Med; 1977 Jan; 62(1):39-46. PubMed ID: 319662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in myocardial ischaemia during isosorbide dinitrate or indoramin therapy in patients with stable angina using relations between the ST segment and heart rate.
    Niveditha Y; Bishop N; Boyle RM; Stoker JB; Mary DA
    Int J Cardiol; 1988 Jun; 19(3):341-54. PubMed ID: 3294190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative evaluation of the efficacy of nitrosorbide and nitroglycerin in acute myocardial infarct patients].
    Zharov EI; Sal'nikov SN; Vertkin AL
    Kardiologiia; 1987 Feb; 27(2):41-6. PubMed ID: 3106696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized double-blind comparison of nifedipine and isosorbide dinitrate in patients with coronary arterial spasm.
    Hill JA; Feldman RL; Pepine CJ; Conti CR
    Am J Cardiol; 1982 Feb; 49(2):431-8. PubMed ID: 6800251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of isosorbide dinitrate and nitroglycerin in relieving angina pectoris during uninterrupted exercise.
    Kattus AA; Alvaro AB; Coulson A
    Chest; 1975 Jun; 67(6):640-6. PubMed ID: 805037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative hemodynamic effects of placebo and oral isosorbide dinitrate in patients with significant coronary artery disease.
    Kasparian H; Wiener L; Duca PR; Gottlieb RS; Brest AN
    Am Heart J; 1975 Jul; 90(1):68-74. PubMed ID: 1094819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term effect of a new delayed-action nitroglycerin compared to isosorbide dinitrate. Double-blind hemodynamic study].
    Witt E; Lehmann HU; Traue P; Hochrein H
    Dtsch Med Wochenschr; 1983 Feb; 108(6):216-20. PubMed ID: 6402355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained effect of orally administered isosorbide dinitrate on exercise performance of patients with angina pectoris.
    Markis JE; Gorlin R; Mills RM; Williams RA; Schweitzer P; Ransil BJ
    Am J Cardiol; 1979 Feb; 43(2):265-71. PubMed ID: 367136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled release isosorbide-5-mononitrate in angina pectoris: a comparison with standard formulation isosorbide dinitrate.
    Parker JO
    Can J Cardiol; 1991 Apr; 7(3):125-30. PubMed ID: 2044014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Coronary therapeutic effectiveness of low-dose IS-5-MN in comparison with the combination IS-5-MH and metipranolol and placebo].
    Müller G; Uberbacher HJ; Glocke M
    Med Welt; 1983 Mar; 34(10):321-7. PubMed ID: 6133205
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of isosorbide dinitrate and nicardipine hydrochloride on postprandial blood pressure in elderly patients with stable angina pectoris or healed myocardial infarction.
    Connelly CM; Waksmonski C; Gagnon MM; Lipsitz LA
    Am J Cardiol; 1995 Feb; 75(4):291-3. PubMed ID: 7832144
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical and circulatory effects of isosorbide dinitrate. Comparison with nitroglycerin.
    Goldstein RE; Rosing DR; Redwood DR; Beiser GD; Epstein SE
    Circulation; 1971 May; 43(5):629-40. PubMed ID: 4996159
    [No Abstract]   [Full Text] [Related]  

  • 20. Nitrate tolerance.
    Parker JO
    Herz; 1984 Jun; 9(3):137-45. PubMed ID: 6430767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.